Review article: Seeing Is Believing–The Eosinophilic Oesophagitis Endoscopic Reference Score Can Serve as a Valuable Clinical Trial Endpoint in Eosinophilic Oesophagitis
PEC has a role in histologic response assessment and should not be completely discounted. Evidence demonstrates that EREFS accurately reflects EoE disease activity and global oesophageal severity, and is ready to be used as a co-primary biologic endpoint in clinical trials.
Authors
- Evan S. Dellon (ORCID: https://orcid.org/0000-0003-1167-1101)
- Ikuo Hirano (ORCID: https://orcid.org/0000-0001-7688-9377)
- Christopher Ma (ORCID: https://orcid.org/0000-0002-4698-9948)
- Gary W. Falk (ORCID: https://orcid.org/0000-0002-7143-1436)
- Glenn T. Furuta (ORCID: https://orcid.org/0000-0003-3262-3571)
- Nirmala Prabu Gonsalves (ORCID: https://orcid.org/0000-0003-0722-6099)
Institutions
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Calgary (CA)
- Children's Hospital Colorado (US)
- University of Pennsylvania (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1111/apt.70474
- Citations
- 1
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 2.01